Anti-SC5A3/ SLC5A3/ BCW2 monoclonal antibody
Anti-SC5A3/ SLC5A3/ BCW2 antibody for FACS & in-vivo assay
Go to SLC5A3/SLC5A3 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-MP1651-Ab-1/ GM-Tg-hg-MP1651-Ab-2 | Anti-Human SLC5A3 monoclonal antibody | Human |
GM-Tg-rg-MP1651-Ab-1/ GM-Tg-rg-MP1651-Ab-2 | Anti-Rat SLC5A3 monoclonal antibody | Rat |
GM-Tg-mg-MP1651-Ab-1/ GM-Tg-mg-MP1651-Ab-2 | Anti-Mouse SLC5A3 monoclonal antibody | Mouse |
GM-Tg-cynog-MP1651-Ab-1/ GM-Tg-cynog-MP1651-Ab-2 | Anti-Cynomolgus/ Rhesus macaque SLC5A3 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-MP1651-Ab-1/ GM-Tg-felg-MP1651-Ab-2 | Anti-Feline SLC5A3 monoclonal antibody | Feline |
GM-Tg-cang-MP1651-Ab-1/ GM-Tg-cang-MP1651-Ab-2 | Anti-Canine SLC5A3 monoclonal antibody | Canine |
GM-Tg-bovg-MP1651-Ab-1/ GM-Tg-bovg-MP1651-Ab-2 | Anti-Bovine SLC5A3 monoclonal antibody | Bovine |
GM-Tg-equg-MP1651-Ab-1/ GM-Tg-equg-MP1651-Ab-2 | Anti-Equine SLC5A3 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-MP1651-Ab-1/ GM-Tg-hg-MP1651-Ab-2; GM-Tg-rg-MP1651-Ab-1/ GM-Tg-rg-MP1651-Ab-2; GM-Tg-mg-MP1651-Ab-1/ GM-Tg-mg-MP1651-Ab-2; GM-Tg-cynog-MP1651-Ab-1/ GM-Tg-cynog-MP1651-Ab-2; GM-Tg-felg-MP1651-Ab-1/ GM-Tg-felg-MP1651-Ab-2; GM-Tg-cang-MP1651-Ab-1/ GM-Tg-cang-MP1651-Ab-2; GM-Tg-bovg-MP1651-Ab-1/ GM-Tg-bovg-MP1651-Ab-2; GM-Tg-equg-MP1651-Ab-1/ GM-Tg-equg-MP1651-Ab-2 |
Products Name | Anti-SLC5A3 monoclonal antibody |
Format | mab |
Target Name | SLC5A3 |
Protein Sub-location | Transmembrane Protein |
Category of antibody | FACS/Biofunctional Antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD). |
Tag | Fc |
Products description | Pre-made anti-SLC5A3 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | Products Developing | Multi-species SC5A3/ SLC5A3/ BCW2 VLP (virus-like particle) (Products Developing) |
ORF Viral Vector | pGMLP001338 | human SLC5A3 Lentivirus plasmid |
ORF Viral Vector | vGMLP001338 | human SLC5A3 Lentivirus particle |
ORF Viral Vector | pGMLPm004084 | mouse Slc5a3 Lentivirus plasmid |
ORF Viral Vector | vGMLPm004084 | mouse Slc5a3 Lentivirus particle |
Target information
Target ID | GM-MP1651 |
Target Name | SLC5A3 |
Gene ID | 6526,53881,114507,698346,445542,101086589,282362,100052070 |
Gene Symbol and Synonyms | BCW2,MRPS6,SLC5A3,SMIT,SMIT1,SMIT2 |
Uniprot Accession | P53794,P53793 |
Uniprot Entry Name | SC5A3_HUMAN,SC5A3_BOVIN |
Protein Sub-location | Transmembrane Protein |
Category | |
Disease | N/A |
Gene Ensembl | ENSG00000198743 |
Target Classification | N/A |
The target: SLC5A3, gene name: SLC5A3, also named as BCW2, SMIT, SMIT1, SMIT2. Enables potassium channel regulator activity and transmembrane transporter binding activity. Predicted to be involved in inositol metabolic process; monosaccharide transmembrane transport; and myo-inositol import across plasma membrane. Predicted to act upstream of or within several processes, including peripheral nervous system development; positive regulation of reactive oxygen species biosynthetic process; and regulation of respiratory gaseous exchange. Located in plasma membrane. Part of perinuclear region of cytoplasm. [provided by Alliance of Genome Resources, Apr 2022].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.